Beyond rejection risk: Identifying ideal candidates for Pre-transplant immune checkpoint inhibitors for hepatocellular carcinoma
{{output}}
Background: The role of immune checkpoint inhibitors (ICI) before liver transplantation (LT) for hepatocellular carcinoma (HCC) remains uncertain. In particular, the optimal treatment duration and the potential long-term oncologi... ...
